Related Experiment Video
Updated: Jun 9, 2026

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
Published on: June 7, 2014
The Renoprotective and Anti-Inflammatory Effects of Human Urine-Derived Stem Cells on Acute Kidney Injury Animals
Yuanyuan Kuang1,2, Chenyu Fan1,2, Xiaojun Long1,2
1Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.
Background:
Acute Kidney Injury (AKI) is defined as a sudden loss of kidney function, which is often caused by drugs, toxins, and infections. The large spectrum of AKI implies diverse pathophysiological mechanisms. In many cases, AKI can be lethal, and kidney replacement therapy is frequently needed. However, current treatments are not satisfying. Developing novel therapies for AKI is essential. Adult stem cells possess regenerative ability and play an important role in medical research and disease treatment.
Methods:
In this study, we isolated and characterized a distinct human urine-derived stem cell, which expressed both proximal tubular cell and mesenchymal stem cell genes as well as certain unique genes.
Results:
It was found that these cells exhibited robust protective effects on tubular cells and anti- inflammatory effects on macrophages in vitro. In an ischemia-reperfusion-induced acute kidney injury NOD-SCID mouse model, transplantation of USCs significantly protected the kidney morphology and functions in vivo.
Conclusion:
In summary, our results highlighted the effectiveness of USCs in protecting from PTC injury and impeding macrophage polarization, as well as the secretion of pro-inflammatory interleukins, suggesting the potential of USCs as a novel cell therapy in AKI.
Insights
Human urine-derived stem cells (USCs) show promise for treating acute kidney injury (AKI). These cells protect kidney cells and reduce inflammation, offering a potential new therapy for AKI.
Area of Science:
- Nephrology
- Regenerative Medicine
- Stem Cell Biology
Background:
- Acute Kidney Injury (AKI) is a sudden decline in kidney function with diverse causes and limited effective treatments.
- Current therapeutic options for AKI are insufficient, necessitating the development of novel treatment strategies.
- Adult stem cells offer regenerative potential, making them attractive candidates for disease treatment and medical research.
Purpose of the Study:
- To isolate and characterize a novel human urine-derived stem cell (USC) population.
- To evaluate the therapeutic potential of USCs in preclinical models of Acute Kidney Injury.
Main Methods:
- Isolation and characterization of human urine-derived stem cells (USCs).
- Assessment of USC effects on tubular cells and macrophages in vitro.
- Evaluation of USC transplantation in a mouse model of ischemia-reperfusion-induced AKI.
Main Results:
- USCs demonstrated protective effects on kidney tubular cells and anti-inflammatory properties against macrophages in vitro.
- Transplantation of USCs significantly preserved kidney morphology and function in a mouse model of AKI in vivo.
- USCs effectively mitigated proximal tubular injury and modulated macrophage polarization.
Conclusions:
- USCs exhibit significant potential as a novel cell-based therapy for Acute Kidney Injury.
- USCs protect against kidney injury by reducing inflammation and preserving kidney structure and function.
- Further research into USC therapy could lead to improved treatments for patients with AKI.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care

